HER2/neu Testing in Breast Carcinoma. Concordance Study Fluorescent In Situ Hybridization (FISH) vs. Chromogenic In Situ Hybridization (CISH)

被引：0
|
作者：
Elavathil, L.
Dhesy, B.
Wiernikowski, J.
Browning, D.
Akhtar-Danesh, N.
Hanna, W.
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
160
引用
收藏
页码：38A / 38A
页数：1
相关论文
共 50 条
  • [21] Automated chromogenic in situ hybridization (CISH) for detection of HER2 gene amplification
    Tubbs, R
    Pettay, J
    Skacel, M
    Hicks, D
    Mele, J
    Powell, R
    Chen, T
    Nita, H
    Grogan, T
    Hainfeld, J
    LABORATORY INVESTIGATION, 2003, 83 (01) : 49A - 50A
  • [22] Use of chromogenic in-situ hybridization (CISH) in determining Her2 status
    Jundi, M
    Selim, S
    Phillips, S
    Garcia, FU
    LABORATORY INVESTIGATION, 2003, 83 (01) : 35A - 35A
  • [23] Chromogenic in situ hybridization (CISH) study of HER2 and Topo2α amplifications in metastatic breast cancer
    Todorovic-Rakovic, N.
    Neskovic-Konstantinovic, Z.
    Nikolic-Vukosavljevic, D.
    CHROMOSOME RESEARCH, 2009, 17 : 95 - 96
  • [24] Fluorescent in situ hybridization (FISH) vs immunohistochemistry (IHC) for determination of Her2/neu status in breast cancer.
    Jimenez, RE
    Wallis, T
    Tabaczka, P
    Visscher, DW
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [25] Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray
    Park, K
    Kim, J
    Lim, S
    Han, SW
    Lee, JY
    MODERN PATHOLOGY, 2003, 16 (09) : 937 - 943
  • [26] HER2 Status Determined on Pre Operative Biopsies and in Operative Specimens: Concordance among Immunohistochemistry (IHC) Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH) Techniques in the CRITHER Study
    Roger, P.
    Lannes, B.
    Balaton, A.
    Hayem, C.
    Campana, F.
    Arnould, L.
    Penault-Llorca, F.
    MacGrogan, G.
    MODERN PATHOLOGY, 2009, 22 : 65A - 65A
  • [27] HER2 Status Determined on Pre Operative Biopsies and in Operative Specimens: Concordance among Immunohistochemistry (IHC) Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH) Techniques in the CRITHER Study
    Roger, P.
    Lannes, B.
    Balaton, A.
    Hayene, C.
    Campana, F.
    Arnould, L.
    Penault-Llorca, F.
    MacGrogan, G.
    LABORATORY INVESTIGATION, 2009, 89 : 65A - 65A
  • [28] HER2 status determined on pre operative biopsies and inoperative specimens: concordance among immunohistochemistry (IHC) fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) techniques in the CRITHER study
    Arnould, L.
    Roger, P.
    MacGrogan, G.
    Lannes, B.
    Hayem, C.
    Campana, F.
    Balaton, A.
    Penault-Llorca, F.
    CANCER RESEARCH, 2009, 69 (02) : 132S - 133S
  • [29] Comparison of HER2 status determination methods: Fluorescent in Situ Hybridization (FISH) vs. dual silver enhanced in Situ Hybridization (SISH)
    Pehlivanoglu, B.
    Zekioglu, O.
    Yeniay, L.
    Yilmaz, R.
    Gokmen, E.
    Ozdemir, N.
    VIRCHOWS ARCHIV, 2016, 469 : S51 - S51
  • [30] HER2 status in breast carcinomas: comparison between silver in situ hybridization, chromogenic in situ hybridization and fluorescence in situ hybridization
    Ali, S. A. Md
    Nurhayati, H. M.
    Munirah, M. A.
    Reena, M. Z.
    Masir, N.
    Chandramaya, S. F.
    Rohaizak, M.
    Asmiati, A.
    Sharifah, N. A.
    Rafie, M. K.
    EJC SUPPLEMENTS, 2010, 8 (05): : 185 - 185
12345